Technology
Health
Pharmaceutical

Aptorum Group

$13.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (1.09%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Aptorum Group and other stocks, options, ETFs, and crypto commission-free!

About

Aptorum Group Limited Class A Ordinary Shares, also called Aptorum Group, is a holding company, which engages in the research and development of life science and pharmaceutical products. It includes therapeutics which seeks to develop various drug molecules and certain technology for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas; and non-therapeutics businesses that encompasses the development of surgical robotics and medical devices, and Aptorum Medical Limited clinic. Read More The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.

Employees
Headquarters
Hong Kong,
Founded
2010
Market Cap
Price-Earnings Ratio
Dividend Yield
Average Volume
3.76K
High Today
$13.20
Low Today
$13.06
Open Price
$13.15
Volume
3.65K
52 Week High
$15.85
52 Week Low
$11.80

Collections

Technology
Health
Pharmaceutical
Therapy
Research And Development
Medical
Medical Devices
2018 IPO
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.